宫颈癌淋巴结转移的影像学诊断

doi:10.3877/cma.j.issn.1673-5250.2021.05.002

宫颈癌是我国最高发的女性生殖道恶性肿瘤之一。淋巴结转移是宫颈癌术后复发的高危因素，可降低早期宫颈癌患者的5年生存率。2018年，国际妇产科联盟(FIGO)正式将淋巴结转移纳入宫颈癌的临床分期标准中，并明确影像学检查在评估宫颈癌原发病灶直径、宫旁侵犯及淋巴结转移中的作用。既往对宫颈癌淋巴结转移的影像学评估，主要是对淋巴结进行形态学评价，可能影响诊断的准确性。目前，功能性影像成像技术，如弥散加权成像(DWI)等越来越多应用于宫颈癌淋巴结转移的评估。笔者拟就宫颈癌淋巴结转移影像学诊断的现状及最新研究进展进行阐述，并着重讨论最新的功能成像技术在诊断宫颈癌淋巴结转移方面的临床应用。

关键词: 宫颈肿瘤, 淋巴转移, 磁共振成像，弥散, 弥散张量成像, 诊断显像, 放射性同位素, 肿瘤分期, 预后危险因素, 女性

Cervical cancer is one of the most common malignancies in women worldwide. Lymph node metastasis is a high risk factor for postoperative recurrence of cervical cancer, and it can reduce 5-year survival rate of patients with early cervical cancer. In 2018, International Federation of Gynecology and Obstetrics (FIGO) formally included lymph node metastasis in clinical staging criteria for cervical cancer, and clarified the role of imaging examination in assessing diameter of the primary cervical cancer lesion, parauterine invasion, and lymph node metastasis. Traditionally, the imaging evaluation of lymph node in patients with cervical cancer mainly depends on its morphology, which may lead to misdiagnosis. Recently, functional imaging modalities, such as diffusion-weighted imaging (DWI) have been used in the evaluation of lymph node metastasis of cervical cancer.This article will expound latest research progresses of multimodalities of imaging in the diagnosis of lymph node metastasis in cervical cancer patients, with focus on the evolving functional imaging.

Key words: Uterine cervical neoplasms, Lymphatic metastasis, Diffusion magnetic resonance imaging, Diffusion tensor imaging, Diagnostic imaging, Radioisotope, Neoplasm staging, Prognosis risk factors, Female

[1]	Cohen PA, Jhingran A, Oaknin A, et al.Cervical cancer[J]. Lancet, 2019, 393(10167):169-182. DOI: 10.1016/S0140-6736(18)32470-X.
[2]	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]．CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338.
[3]	Koh WJ, Abu-Rustum NR, Bean S, et al. Cervical cancer, version 3. 2019, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2019, 17(1):64-84.DOI: 10.6004/jnccn.2019.0001.
[4]	Frumovitz M, Euscher ED, Deaver MT, et al. " Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer[J]. Gynecol Oncol, 2012，127(3):467-471. DOI: 10.1016/j.ygyno.2012.08.015.
[5]	Bhatla N, Berek JS, Cuello FM, et al. Revised FIGO staging for carcinoma of the cervix uteri[J]. Int J Gynaecol Obstet, 2019, 145(1):129-135. DOI: 10.1002/ijgo.12749.
[6]	Paño B, Sebastià C, Ripoll E, et al.Pathways of lymphatic spread in gynecologic malignancies[J]. Radiographics, 2015, 35(3):916-945. DOI: 10.1148/rg.2015140086.
[7]	Balaya V, Mathevet P, Magaud L，et al. Predictive factors of unexpected lymphatic drainage pathways in early-stage cervical cancer[J]. Gynecol Oncol, 2019, 154(1):102-109. DOI: 10.1016/j.ygyno.2019.04.008.
[8]	Devine C, Viswanathan C, Faria S, et al. Imaging and staging of cervical cancer[J]．Semin Ultrasound CT MR, 2019, 40(4):280-286. DOI: 10.1053/j.sult.2019.03.001.
[9]	Xiao M, Yan B, Li Y, et al. Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: a Meta-analysis[J]．Eur Radiol, 2020, 30(3):1405-1418. DOI：10.1007/s00330-019-06461-9.
[10]	唐英，唐方祥，胡辉权，等. 淋巴细胞与单核细胞比值对早期宫颈癌患者盆腔淋巴结转移的预测价值[J/CD]. 中华妇幼临床医学杂志(电子版)，2020，16 (1): 100-106. DOI: 10.3877/cma.j.issn.1673-5250.2020.01.013.
[11]	Liu B, Gao S, Li S. A comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography/CT, and diffusion weighted imaging-MRI for detecting the lymph nodes metastases in patients with cervical cancer: a Meta-analysis based on 67 studies[J]. Gynecol Obstet Invest, 2017, 82(3):209-222. DOI: 10.1159/000456006.
[12]	Perucho JAU, Chiu KWH, Wong EMF, et al. Diffusion-weighted magnetic resonance imaging of primary cervical cancer in the detection of sub-centimetre metastatic lymph nodes[J]．Cancer Imaging, 2020, 20(1):27. DOI: 10.1186/s40644-020-00303-4.
[13]	Adam JA, van Diepen PR, Mom CH, et al.[¹⁸F]FDG-PET or PET/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: a systematic review of the literature[J]．Gynecol Oncol, 2020, 159(2):588-596.DOI: 10.1016/j.ygyno.2020.08.021.
[14]	Xu C, Li X, Shi Y, et al.Combinative evaluation of primary tumor and lymph nodes to predict pelvic lymphatic metastasis in cervical cancer: an integrated PET-IVIM MRI study[J]．Cancer Imaging, 2020, 20(1):21.DOI: 10.1186/s40644-020-00298-y.
[15]	Hoogendam JP, Zweemer RP, Hobbelink MG, et al. ⁹⁹mTc-nanocolloid SPECT-MRI fusion for the selective assessment of non-enlarged sentinel lymph nodes in patients with early stage cervical cancer[J]. J Nucl Med, 2016, 57(4):551-556. DOI：10.2967/jnumed.115.164780.
[16]	Huang BX, Fang F．Progress in the study of lymph node metastasis in early-stage cervical cancer[J]．Curr Med Sci, 2018, 38(4):567-574. DOI: 10.1007/s11596-018-1915-0.
[17]	Wáng YX, Idée JM. A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging[J]．Quant Imaging Med Surg, 2017, 7(1):88-122. DOI: 10.21037/qims.2017.02.09.
[18]	Atri M, Zhang Z, Marques H, et al. Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: results of ACRIN 6671/GOG 0233[J]. Eur J Radiol Open，2015, 2(3):11-18. DOI：10.1016/j.ejro.2014.11.002.
[19]	van Nijnatten TJA, Schipper RJ, Lobbes MBI, et al.Diagnostic performance of gadofosveset-enhanced axillary MRI for nodal (re)staging in breast cancer patients: results of a validation study[J]．Clin Radiol，2018，73(2):168-175. DOI: 10.1016/j.crad.2017.09.005.
[20]	Fournier LS, Bats AS, Durdux C, et al.Diffusion MRI: technical principles and application to uterine cervical cancer[J]．Cancer Radiother, 2020, 24(5):368-373.DOI: 10.1016/j.canrad.2020.02.008.
[21]	Zhang A, Song J, Ma Z, et al.Application of apparent diffusion coefficient values derived from diffusion-weighted imaging for assessing different sized metastatic lymph nodes in cervical cancers[J]．Acta Radiol, 2020, 61(6):848-855.DOI: 10.1177/0284185119879686.
[22]	Song J, Hu Q, Huang J, et al. Combining tumor size and diffusion-weighted imaging to diagnose normal-sized metastatic pelvic lymph nodes in cervical cancers[J]．Acta Radiol, 2019, 60(3):388-395. DOI: 10.1177/0284185118780903.
[23]	Li X, Wang P, Li D, et al. Intravoxel incoherent motion MR imaging of early cervical carcinoma: correlation between imaging parameters and tumor-stroma ratio[J]. Eur Radiol, 2017, 28(5):1-9.DOI: 10.1007/s00330-017-5183-3.
[24]	Guo L, Liu X, Liu Z, et al. Differential detection of metastatic and inflammatory lymph nodes using intravoxel incoherent motion diffusion-weighted imaging[J]. Magn Reson Imaging, 2020, 65:62-66. DOI：10.1016/j.mri.2019.10.005.
[25]	Wang H, Zhu L, Li G, et al.Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI[J]．Acta Radiol, 2020, 61(8):1087-1095. DOI: 10.1177/0284185119890086.
[26]	Yamada I, Yamauchi S, Uetake H, et al. Diffusion tensor imaging of rectal carcinoma: clinical evaluation and its correlation with histopathological findings[J]．Clin imaging, 2020，67:177-188. DOI：10.1016/j..2020.08.005.
[27]	Kim JY, Kim JJ, Kim S，et al. Diffusion tensor magnetic resonance imaging of breast cancer: associations between diffusion metrics and histological prognostic factors[J]. Eur Radiol, 2018, 28(8):3185-3193. DOI: 10.1007/s00330-018-5429-8.
[28]	Feng Q, Fang W, Sun XP，et al. Renal clear cell carcinoma: diffusion tensor imaging diagnostic accuracy and correlations with clinical and histopathological factors[J]. Clin Radiol, 2017, 72(7):560-564. DOI: 10.1016/j.crad.2017.02.016.
[29]	Yamada I, Wakana K, Kobayashi D, et al. Endometrial carcinoma: evaluation using diffusion-tensor imaging and its correlation with histopathologic findings[J]. J Magn Reson Imaging, 2019, 50(1):250-260. DOI: 10.1002/jmri.26558.
[30]	Yamada I, Oshima N, Wakabayashi A, et al.Diffusion-tensor imaging of uterine cervical carcinoma: correlation with histopathologic findings[J]．J Comput Assist Tomogr, 2020, 44(3):426-435.DOI：10.1097/RCT.0000000000001014.
[31]	Yamada I, Yoshino N, Hikishima K, et al. Oral carcinoma: clinical evaluation using diffusion kurtosis imaging and its correlation with histopathologic findings[J]．Magn Reson Imaging, 2018, 51:69-78. DOI: 10.1016/j.mri.2018.04.014.
[32]	Chen W, Li L, Yan Z, et al.Three-dimension amide proton transfer MRI of rectal adenocarcinoma: correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging[J]. Eur Radiol, 2021，31(5):3286-3296. DOI: 10.1007/s00330-020-07397-1.
[33]	Meng N, Wang X, Sun J, et al. A comparative study of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in the diagnosis and evaluation of breast cancer[J]．Eur Radiol, 2021, 31(3):1707-1717. DOI: 10.1007/s00330-020-07169-x.
[34]	Meng N, Wang X, Sun J, et al. Application of the amide proton transfer-weighted imaging and diffusion kurtosis imaging in the study of cervical cancer[J]. Eur Radiol, 2020, 30(10):5758-5767.DOI: 10.1007/s00330-020-06884-9.
[35]	Wang M, Perucho JAU, Chan Q, et al. Diffusion kurtosis imaging in the assessment of cervical carcinoma[J]．Acad Radiol, 2020, 27(5):e94-e101.DOI: 10.1016/j.acra.2019.06.022.
[36]	Yamada I, Oshima N, Wakana K, et al. Uterine cervical carcinoma: evaluation using non-gaussian diffusion kurtosis imaging and its correlation with histopathological findings[J]. Comput Assist Tomogr, 2021, 45(1):29-36.DOI: 10.1097/RCT.0000000000001042.
[37]	Zhang X, Dong Y, Song Q, et al. The role of multiparametric magnetic resonance imaging in the study of primary tumor and pelvic lymph node metastasis in stageⅠ_B1-Ⅱ_A1 cervical cancer[J]. J Comput Assist Tomogr, 2020, 44(5):750-758.DOI：10.1097/RCT.0000000000001084.
[38]	Bai Z, Shi J, Yang Z, et al. Quantitative kinetic parameters of primary tumor can be used to predict pelvic lymph node metastasis in early-stage cervical cancer[J]．Abdom Radiol (NY), 2021, 46(3):1129-1136.DOI: 10.1007/s00261-020-02762-6.
[39]	Abdel Razek AAK, Talaat M, El-Serougy L, et al.Clinical applications of arterial spin labeling in brain tumors[J]. J Comput Assist Tomogr, 2019, 43(4):525-532. DOI: 10.1097/RCT.0000000000000873.
[40]	Zhang JL, Lee VS.Renal perfusion imaging by MRI[J]．J Magn Reson Imaging, 2020, 52(2):369-379. DOI: 10.1002/jmri.26911.
[41]	Aramendía-Vidaurreta V, Echeverría-Chasco R, Vidorreta M, et al.Quantification of myocardial perfusion with vasodilation using arterial spin labeling at 1.5T[J]．J Magn Reson Imaging, 2021, 53(3):777-788. DOI: 10.1002/jmri.27396.
[42]	Abdel Razek AAK, Nada N. Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma[J]．Eur Arch Otorhinolaryngol, 2018, 275(5):1301-1307.DOI: 10.1007/s00405-018-4950-3.
[43]	Li Y, Li X, Yu X, et al. Investigating the value of arterial spin labeling and intravoxel incoherent motion imaging on diagnosing nasopharyngeal carcinoma in T1 stage[J]．Cancer Imaging, 2020, 20(1):62. DOI：10.1186/s40644-020-00339-6.
[44]	隋时，辛军. 早期宫颈癌¹⁸F-FDG PET/CT显像盆腔高摄取淋巴结的良恶性鉴别[J]. 中国临床医学影像杂志，2017, 28(4): 273-276. DOI：10.3969/j.issn.1008-1062.2017.04.010.
[45]	Yang Z, Xu W, Ma Y, et al. ¹⁸F-FDG PET/CT can correct the clinical stages and predict pathological parameters before operation in cervical cancer[J]. Eur J Radiol, 2016, 85(5): 877-884. DOI: 10.1016/j.ejrad.2016.02.010.
[46]	Rossetti D, Vitale SG, Tropea A, et al.New procedures for the identification of sentinel lymph node: shaping the horizon of future management in early stage uterine cervical cancer[J]．Updates Surg, 2017, 69(3):383-388. DOI：10.1007/s13304-017-0456-6.
[47]	Frumovitz M, Plante M, Lee PS, et al.Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial[J]．Lancet Oncol, 2018, 19(10):1394-1403. DOI：10.1016/S1470-2045(18)30448-0.

[1]	石皆春, 范子玉, 邢燕. 不同筛查方法预警宫颈原位腺癌的效能[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 575-581.
[2]	张少华, 林爱齐, 张玉, 董晓云, 刘红英. HLA和IL基因多态性及其与复发性自然流产的相关性[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 251-259.
[3]	唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[4]	刘哲魁, 马文星, 聂灵芝, 吴云桦, 单良, 王泽正. HALP评分联合术前检查预测老年胃癌淋巴结转移的价值[J/OL]. 中华普通外科学文献(电子版), 2024, 18(03): 209-215.
[5]	张锐, 赵舸. T1和T2期胆囊癌外科治疗研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(03): 225-228.
[6]	贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[7]	达热拜·热达提, 刘林, 赵为民, 孟涛, 雷程, 金博, 毕建军, 李新宇, 王海江. 中低位直肠癌新辅助放化疗后侧方淋巴结清扫术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 415-418.
[8]	刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[9]	刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[10]	林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊（第15期）——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[11]	陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[12]	吉莉, 苏云楠, 王斌, 沈滔, 刘团结, 毛蕾, 徐玉萍, 张婷, 王博. 急性缺血性脑卒中患者脑白质微结构改变对长期认知功能损伤的预测价值研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 193-200.
[13]	赵文元, 田玉廷, 张吉海, 张军. CT肿瘤体积测量参数结合实验室指标对结肠癌术前分期预判的价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 306-309.
[14]	黎璞, 生秀杰. 妊娠合并子宫颈癌的管理[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 202-208.
[15]	梁铭垚, 袁健瑜, 关雨霏, 左思程, 阳新明, 陈巧燕. 多壳扩散磁共振成像在缺血性卒中模型的应用[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 362-368.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Imaging diagnosis of lymph node metastasis in cervical cancer

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Imaging diagnosis of lymph node metastasis in cervical cancer